Improving Patient Experience, Enhancing Data-Driven Insights, and Optimising Clinical Trial Performance
27 January 2026 | London, UK
As the global clinical trial market is going through rapid growth, it is predicted that by 2025, 40% of all trials will incorporate decentralised elements. For that reason, it has become increasingly crucial to advance technology usage in clinical trials.
Although technological advancements in clinical trials such as AI and wearables can lead to great benefits such as increased operational efficiency, patient satisfaction and the ease of data collection, implementing more technology can be costly, complex, and difficult to navigate.
Join us at the Disruptive Technology for Clinical Trials Summit Europe alongside clinical trial industry leaders as they share their insights on successfully leveraging disruptive technologies to improve clinical trial innovation.
2025 European Clinical Trial Technology Expert Speakers Include:
Dr Fabian Kreimendahl
Medical Evidence Biostatistics Manager
The Janssen Pharmaceutical Companies of Johnson & Johnson
Marcus Greenhill
Sales Director Digital Healthcare (Pharma) Systems EMEA
Analog Devices
Guido Radack
Former VP of Digital Transformation in Clinical Development
Bayer
Andrew Gvozdanovic
International Medical Manager
Novo Nordisk
Paul Cooper
Healthcare Strategy Leader
Roche
Dr Sachin S Shah
Digital Biomarker Lead
GSK
Key Themes Include:
Attending this event will enable you to:
- Foster a Culture of Innovation: Build an organisational culture that embraces technological advancements and innovation in clinical trials to create an environment of continuous innovation.
- Harness Cutting-Edge Innovations: Discover how remote monitoring tools, wearables, and AI can revolutionise study recruitment, clinical trial delivery, and study outcomes.
- Enhance the Patient Experience: Boost patient engagement using digital solutions, such as e-PRO, eCOA, eConsent, and more to enhance patient satisfaction and compliance.
- Optimise Data Strategies: Leverage innovative tools to enhance data capture and analysis for more real-time, accurate insights into the progress of study participants.
- Measure Value: Track key performance indicators pre- and post-technology implementation to prove ROI and enhance long-term success.
Who You Will Meet:
VPs, Directors, Heads, Managers from:
- Clinical R&D / Operations
- Clinical Trial Innovation
- Clinical Development
- Digital Health / Digital Medicine
- DCT / Decentralised clinical trials / hybrid trials
- Patient Experience, Patient Engagement / Patient-centred Outcomes
- Regulatory / Clinical Affairs
- Biostatistics / biomarkers / bioinformatics / data generation / data strategy
Our sponsors include technology, service and solution providers specialising in:
- Remote-monitoring tools
- Wearables / Biosensors
- Data Analytics Software & Platforms
- Patient Experience Management Platforms / Mobile & Web Applications
- AI (Artificial Intelligence) / ML (Machine Learning
- ePRO / Electronic patient-reported outcome
- eCOA / Electronic Clinical Outcome Assessment
- eSource / Electronic Data Capture / DDC Direct Data Capture
- eConsent / Digital Enrolment
Disruptive Technologies for Clinical Trials Europe Sponsorship Opportunities
Get in touch to position your organisation as a clinical trials technology expert amongst the most prominent and influential players in the development of Disruptive Technologies, IoT, Wearables, Data & Analytics, and AI/ML to senior decision makers.
2025 Sponsors
Testimonials
Content Highlights
Top 10 Takeaways: Ethical Implications of AI Use Infographic
Panellists from Novartis, ICON PLC, and Astellas Pharma explored the ethical implications of AI use in clinical trials, paying attention to emerging risks, key considerations, and future trends. If you missed the discussion, we’re pleased to share our top 10 takeaways from this collaborative discussion. From the importance of transparency in AI systems to the… Read more »
Ethical Implications of AI Use in Clinical Trials Virtual Roundtable Discussion
The use of artificial intelligence in clinical trials holds immense promise, from accelerating drug discovery to optimizing patient recruitment and trial design. However, the integration of AI also introduces complex ethical considerations that must be carefully navigated. Watch the recording as panellists from Novartis, ICON PLC, and Astellas Pharma explored the ethical implications of AI… Read more »
Disruptive Technology for Clinical Trials Europe 2025 Sponsorship Pack
Complete the form below to view the sponsorship information for Disruptive Technology for Clinical Trials Europe 2025 in London, UK on 28 January 2025. Full Name(Required) First Last Job Title(Required)Company Name(Required)Email(Required) Country AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic... Read more »
Whitepaper: Harnessing the Full Potential of Real-World Data and Evidence to Enhance Clinical Trial Design and Effectiveness
This whitepaper explores the transformative potential of real-world data and evidence in clinical trials, with industry experts sharing their key insights on integrating diverse data sources to enhance trial design, recruitment, and outcomes. Clinical trial technology specialists from AstraZeneca, Parexel, Novartis and GSK examine key challenges in data quality and regulatory compliance, while outlining strategies… Read more »
